Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Zyprexa'

Posted by Jane Akre
January 05, 2010 3:10 PM

Eli Lilly & Co.has had an FDA expert panel meeting canceled over its application to expand the use of its antidepressant, Cymbalta.

Posted by Jane Akre
November 23, 2009 11:58 AM

Abilify by Bristol Myers Squibb was just approved by the FDA for treatment of autism-related irritability and acting out. It is among a group of antipsychotics that cause weight gain in users.

Posted by Jane Akre
October 28, 2009 11:34 PM

Atypical antipsychotics used in young patients for the first time led to a weight gain of anywhere from 11 to 19 pounds in just 11 weeks and an increase in cholesterol and triglycerides, making some question whether the drugs are a long-term solution for young people with psychiatric disorders.

Posted by Jane Akre
June 10, 2009 1:15 PM

While Risperdal is already approved for use in adolescents, three other makers of powerful atypical anti-psychotics are seeking FDA approval for use in the young.  The drugs are effective in some, but others say they can be fatal and are known to cause weight gain and increase the risk of diabetes. 

Posted by Jane Akre
May 29, 2009 3:24 PM

When seven-year-old Gabriel Myers hanged himself in a foster care home, Florida immediately conducted an audit on how many kids, like Gabriel, were on mind-altering drugs.  Up to three times the general population are put on psychiatric drugs with the numbers increasing to one-in-three among teens in group homes.  

Posted by Jane Akre
May 18, 2009 2:59 PM

When Florida began requiring physicians to obtain approval from the state before prescribing antipsychotics to children under the age of six, something dramatic happened - prescriptions dropped 75 percent. The same trend is being seen nationwide. 

Posted by Jane Akre
March 24, 2009 4:29 PM

In one of the largest imaging studies on whether depression runs in families - researchers find that a thinning in the right hemisphere of the brain appeared to be linked to a risk of depression.

Posted by Jane Akre
March 23, 2009 10:17 AM

Symbyax will be used for patients who have bipolar depression that is resistant to treatment. It also helps Lilly get around the patent expiration for Prozac.

Posted by Jane Akre
January 16, 2009 2:17 PM

Eli Lilly will have to pay the federal government more than $1.4 billion to settle an off-label marketing scheme for its prescription drug, Zyprexa. The settlement is the largest amount paid by a single defendant in the history of the Department of Justice and was initiated by six former Lilly drug marketing representatives who became whistleblowers over the aggressive off-label marketing for the antipsychotic.

Posted by Chrissie Cole
January 15, 2009 11:07 PM

If schizophrenia runs in a family, bipolar disorder most likely does as well (and vice versa), suggests new research. A new study, published online in the January issue of the journal The Lancet, suggests both disorders share common genetic causes.

Posted by Chrissie Cole
November 20, 2008 2:13 PM

In a routine pediatric safety review on Tuesday, an outside panel of experts unanimously requested more long-term data on the side effects of prescribing powerful antipsychotic drugs to children including Risperdal and Zyprexa.

Posted by Jane Akre
October 10, 2008 11:58 AM

Seroquel's new extended release formula will have an extended patent, and presumably bring expanded profits for AstraZeneca, despite the controversy about the drug's side effects.

Posted by Chrissie Cole
September 10, 2008 11:30 PM

A federal district court judge granted a motion to unseal hundreds of confidential documents about Zyprexa, Eli Lilly’s popular antipsychotic drug. The decision came as part of another ruling granting class-action status to a case brought by pension funds, labor unions and insurance companies that want Eli Lilly to reimburse them for millions of dollars overspent on Zyprexa.

Posted by Jane Akre
July 30, 2008 4:20 PM

Published studies uncover a genetic component to schizophrenia that had never before been seen. For a disease that has seen few breakthroughs, these discoveries will help target therapies and earlier diagnosis.

Posted by Jane Akre
June 17, 2008 11:25 AM

With a new stronger authority, the FDA will now mandate that the conventional antipsychotics carry the same black box warning as atypical antipsychotics, used on elderly patients with dementia to quiet agitation, and behavioral problems. 

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes